Wei Chen

12PUBLICATIONS

26CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical biotechnology diagnostics (incl. biosensors)Epidemiological modellingMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (12)

Sort by Publication Date:

|May 21, 2026

Anti-BCMA/GPRC5D CAR T in relapsed or refractory multiple myeloma patients with extraosseous extramedullary disease.

|May 13, 2026

Prospects of Chimeric Antigen Receptor T-Cell Therapy in Myelofibrosis: From Immunopathogenesis to Therapeutic Strategies.

|Oct 16, 2025

Advances in the Diagnosis and Treatment of Myeloproliferative Neoplasms (MPNs).

Xinyu Ma, Zhibo Zhou, Shuyu Gu

|Jun 24, 2025

Endothelial activation and stress index (EASIX) as a predictive biomarker for survival in patients with T-cell lymphoma.

Miao Li, Huimin Chen, Ling Gao

|Mar 16, 2025

Genetic and epigenetic mechanisms of GPRC5D loss after anti-GPRC5D CAR T-cell therapy in multiple myeloma.

Sha Ma, Jieyun Xia, Miao Zhang

|Nov 01, 2024

Distinguishing clinical and imaging characteristics of primary central nervous system lymphoma from high-grade glioma and metastatic brain tumors.

Qian Hu, Shenyang Zhang, Rui Xue Ma

Pageof 2

Frequent Collaborators

Kailin Xu

Jiang Cao

Feng Zhu

Zhenyu Li

Yuekun Qi

Wei Sang

Yanlei Zhang

Bin Pan

Xiaoming Fei

Jianlin Qiao

Frequent Collaborators

Kailin Xu

Jiang Cao

Feng Zhu

Zhenyu Li